Changes in parietal cell structure and function in HIV disease
- PMID: 8689917
- DOI: 10.1007/BF02088565
Changes in parietal cell structure and function in HIV disease
Abstract
The mechanisms underlying acid secretory failure in patients with HIV disease are unknown. We evaluated, in a series of preliminary studies, changes associated with parietal cell structure and function in early and late HIV disease, in an attempt to elucidate possible underlying mechanisms. Gastric acid and intrinsic factor secretion, vitamin B12 absorption, and light and electron microscopic evaluation of gastric mucosa were evaluated in patients with early and late HIV infection (AIDS) and compared to non-HIV-infected controls. Immunolocalization of HIV-related antigens in gastric mucosa was also examined. Fasting gastric juice pH and intrinsic factor (IF) concentration in AIDS and HIV infected subjects were significantly different from controls (P = 0.012 and P = 0.025, respectively for pH, and 0.029 and 0.035 for IF; ANOVA LSD test). By contrast, maximal acid output (MAO) was significantly lower in AIDS, but not HIV-infected subjects (P = 0.043 and P = 0.322, respectively). Similarly, Schilling test phases 1 and 2 results were significantly lower in AIDS, but not HIV-infected subjects. Varying degrees of vacuolar degeneration of parietal cells were seen on light microscopy. On electron microscopy (EM), tubulovesicles were reduced and intracellular canaliculi dilated with striking loss of microvilli. Immunofluorescent staining with antibodies to gp120, gp41, p24, and p17 demonstrated positive punctate signals in the cytoplasm of gastric glands, which includes parietal cells. Immunogold EM with anti-gp120, localized predominantly to the microvilli of intracellular canaliculi in parietal cells. Abnormal secretory function of parietal cells occurs early in HIV disease, affects acid as well as intrinsic factor secretion, and is associated with morphological changes in the acid secretory apparatus.
Similar articles
-
Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption.Am J Gastroenterol. 1992 Dec;87(12):1781-8. Am J Gastroenterol. 1992. PMID: 1449141
-
Human intrinsic factor secretion: immunocytochemical demonstration of membrane-associated vesicular transport in parietal cells.J Cell Biol. 1981 Sep;90(3):644-55. doi: 10.1083/jcb.90.3.644. J Cell Biol. 1981. PMID: 7287818 Free PMC article.
-
The cryofixation of isolated rat gastric mucosa provides new insights into the functional transformation of gastric parietal cells: an in vitro experimental model study.Arch Histol Cytol. 2005 Sep;68(3):151-60. doi: 10.1679/aohc.68.151. Arch Histol Cytol. 2005. PMID: 16276021
-
Functional transformation of gastric parietal cells and intracellular trafficking of ion channels/transporters in the apical canalicular membrane associated with acid secretion.Biol Pharm Bull. 2011;34(6):813-6. doi: 10.1248/bpb.34.813. Biol Pharm Bull. 2011. PMID: 21628877 Review.
-
Gastric oxyntic cell structure as related to secretory activity.Histol Histopathol. 1997 Jul;12(3):739-54. Histol Histopathol. 1997. PMID: 9225157 Review.
Cited by
-
Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus.Pharmacotherapy. 2011 Mar;31(3):253-61. doi: 10.1592/phco.31.3.253. Pharmacotherapy. 2011. PMID: 21361735 Free PMC article.
-
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report.Dig Dis Sci. 2005 Apr;50(4):617-22. doi: 10.1007/s10620-005-2545-5. Dig Dis Sci. 2005. PMID: 15844690 No abstract available.
-
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.Clin Pharmacokinet. 1999 Mar;36(3):233-54. doi: 10.2165/00003088-199936030-00004. Clin Pharmacokinet. 1999. PMID: 10223170 Review.
-
Vitamin C Improves Dasatinib Concentrations Under Hypochlorhydric Conditions of the Simulated Stomach Duodenum Model.Pharm Res. 2022 Sep;39(9):2217-2226. doi: 10.1007/s11095-022-03321-y. Epub 2022 Jul 1. Pharm Res. 2022. PMID: 35778632
-
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects.Clin Pharmacokinet. 2011 Aug;50(8):531-40. doi: 10.2165/11592660-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21740076 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous